| Date | Form | Description | Docs | XBRL | Pages |
| 03/25/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/25/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/24/21 | 8-K | Current report filing |
|
25 | |
| 03/24/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
24 | |
| 03/23/21 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
1 | |
| 03/22/21 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
1 | |
| 03/22/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
24 | |
| 03/11/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 02/05/21 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 02/05/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
Read More...Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...